Mesa Laboratories (MLAB) Short term Debt (2011 - 2025)

Mesa Laboratories has disclosed Short term Debt across 11 years of filings, most recently posting $4.7 million for Q3 2025.

• Short term Debt for Q3 2025 came in at $4.7 million, down 95.17% year-over-year; the trailing twelve-month figure through Sep 2025 was $4.7 million (down 95.17% YoY), and the FY2025 annual result was $3.8 million, changed N/A from the prior year.
• Short term Debt came in at $4.7 million for Q3 2025 at Mesa Laboratories, up from $4.2 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $97.0 million in Q3 2024 to a low of $235000.0 in Q1 2021.
• The 3-year median for Short term Debt is $3.8 million (2024), against an average of $16.8 million.
• Peak annual rise in Short term Debt reached 12.51% in 2025, while the deepest fall reached 95.17% in 2025.
• Mesa Laboratories' Short term Debt stood at $235000.0 in 2021, then soared by 1495.74% to $3.8 million in 2024, then increased by 25.01% to $4.7 million in 2025.
• The last three Short term Debt figures came in at $4.7 million (Q3 2025), $4.2 million (Q2 2025), and $3.8 million (Q1 2025), per Business Quant data.